- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01955005
Use of the My HealtheVet for Health Information Sharing
8. januar 2016 oppdatert av: VA Office of Research and Development
Pilot of My HealtheVet Training to Improve Co-Managed Care for Veterans
This study aims to conduct a pilot of an intervention to improve care coordination between VA and non-VA providers using the Department of Veteran's Affairs' (VA) personal health record, My HealtheVet (MHV).
Participants will be randomized to receive either training on 1) how to use My HealtheVet to share VA health information or 2) training on how to how to search the Internet for health information and decide which Internet sites have good quality information.
The investigators predict that Veterans who receive the My HealtheVet training will have fewer medication errors and duplication of services between the VA and outside providers.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
This study aims to conduct a pilot of an intervention to improve care coordination between VA and non-VA providers using the Department of Veteran's Affairs' (VA) personal health record, My HealtheVet (MHV).
Background: The Blue Button feature of My HealtheVet allows Veterans to print out a comprehensive summary of their health that can be shared with non-VA providers.
Dual use is common and has been associated with negative health outcomes including higher mortality.
Preliminary data collected by the principal investigator in collaboration with the My HealtheVet Performance Evaluation workgroup shows that few Veterans enrolled in My HealtheVet use it to inform either VA or non-VA providers of their care.
To remedy this, the principal investigator has developed an online video and companion paper-based training.
This training will teach Veterans how to use the Blue Button feature and why it is important to share the print out with their non-VA provider.
Methods: To participate, Veterans must have an upcoming non-VA provider appointment, be prescribed 5 or more medications, and be registered on My HealtheVet with a premium account.
Participants will be randomized to receive either training on how to use the Blue Button or training on how to search for health information on the Internet and if that information is good quality.
Veterans in both arms will receive training materials and phone support.
After the non-VA provider visit, both the Veteran and the provider will be asked to indicate what occurred during the visit, including whether or not the Veteran gave the provider the Blue Button print out.
Both Veterans and providers will also be asked to complete a 15-minute qualitative interview about their experience during the visit.
Medical records of the non-VA provider visit will be obtained.
Outcomes: The main outcome for the study is whether the patient provided the non-VA provider a copy of his or her health information printed from My HealtheVet.
In addition, comparison between the VA and non-VA provider records will be conducted to test whether Veterans who completed the training had 1) better medication reconciliation between the VA and the non-VA provider and 2) fewer instances of therapeutic or laboratory duplication.
The results of this pilot will be used to inform a larger randomized controlled trial of the training intervention.
Studietype
Intervensjonell
Registrering (Faktiske)
60
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Iowa
-
Iowa City, Iowa, Forente stater, 52246-2208
- Iowa City VA Health Care System, Iowa City, IA
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Upcoming Non-VA provider appointment
- Take 5 or more prescribed medications
- Have or obtain a My HealtheVet premium account
- Access to computer, printer, & Internet to complete study protocol
Exclusion Criteria:
- No non-VA provider or upcoming appointment
- Less than 5 medications
- No premium MHV account
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: My HealtheVet Training
Participants will be asked to watch an on-line training video, review written materials, and print a document containing health information from their My HealtheVet account.
|
Participants will be asked to watch an on-line training video, review written materials, and print a document containing health information from their My HealtheVet account.
|
Aktiv komparator: Internet Skills Training
Participants will review written training materials to learn how to search the Internet for health information and how to decide which Internet sites have good quality information.
|
Participants will review written training materials to learn how to search the Internet for health information and how to decide which Internet sites have good quality information.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Percentage of Participants Who Brought Their VA Information From My HealtheVet to Their Visit With Their Non-VA Provider
Tidsramme: Within 1-2 week of non-VA provider visit
|
The primary outcome is whether or not the veteran brings their VA information from My HealtheVet to their visit with their non-VA provider.
Providers will be asked to complete a form during the appointment where assessment of sharing this information is embedded in a checklist of possible visit activities.
Participants will also if they provided this information to the provider in the event the provider opts to not return the form.
|
Within 1-2 week of non-VA provider visit
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Proportion of Total Number of Unique Medications Discrepant Between VA and Non-VA Medication Lists
Tidsramme: Typically within 1 month of non-VA provider visit
|
A medication discrepancy metric was be calculated by comparing the current VA medication list with the non-VA provider medication list to determine the total number of distinct medications.
The number of discrepant medications between these lists is the numerator and is divided by the total number of distinct medications on both lists combined.
This will yield a range of scores between score between 0 and 1, with 1 indicating perfect agreement between the two lists.
|
Typically within 1 month of non-VA provider visit
|
Proportion of Participants Who Received One or More Duplicate Laboratory Tests in the Non-VA Provider Visit.
Tidsramme: Typically within 1 month of non-VA provider visit
|
Therapeutic duplication will be defined as concurrent use of more than one medication from the same therapeutic class.
For laboratory duplication, we will review non-VA and VA medical records 6 months prior to the non-VA provider visit.
Each patient will be assigned a dichotomous indicator for whether they received therapeutic duplication and/or laboratory duplication during their non-VA provider visit
|
Typically within 1 month of non-VA provider visit
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Carolyn L Turvey, PhD MS, Iowa City VA Health Care System, Iowa City, IA
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. oktober 2013
Primær fullføring (Faktiske)
1. september 2014
Studiet fullført (Faktiske)
1. september 2014
Datoer for studieregistrering
Først innsendt
20. august 2013
Først innsendt som oppfylte QC-kriteriene
26. september 2013
Først lagt ut (Anslag)
7. oktober 2013
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
5. februar 2016
Siste oppdatering sendt inn som oppfylte QC-kriteriene
8. januar 2016
Sist bekreftet
1. januar 2016
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- PPO 13-178
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Kronisk sykdom
-
Clínica de Oftalmología de Cali S.AFullførtMeibomian kjerteldysfunksjon | Eyes Dry ChronicColombia
-
Alcon ResearchFullført
-
Jules Bordet InstituteMacopharma; Belgian Hematological SocietyRekrutteringRefractory Chronic Graft Versus Host Disease (cGVHD)Belgia
-
Occyo GmbHUniversity Clinic for Ophthalmology and Optometry- SalzburgFullførtLimbal stamcelle mangel | Hornhinnesykdom | Eyes Dry Chronic | Kronisk konjunktivitt i begge øyne | Øyelesjon | Øyesykdom; Grå stær | Øyne Tørr følelse av | Hornhinne betent | Hornhinne; Skade, slitasje | HornhinneinfeksjonØsterrike
-
Medical University of ViennaFullførtSekundær hyperparathyroidisme | CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder | NyreerstatningØsterrike
-
Novartis PharmaceuticalsTilgjengeligPrimær myelofibrose (PMF) | Polycytemi Vera (PV) | Post polycytemi myelofibrose (PPV MF) | Trombocytemi myelofibrose (PET-MF) | Alvorlig/svært alvorlig COVID-19-sykdom | Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD) | Steroid Refractory Chronic Graft Versus Host Disease (SR cGVHD)
Kliniske studier på My HealtheVet Training
-
Zhu DianRekrutteringBarns atferd | Amblyopi | Overholdelse, behandling | Amblyopi okklusjonKina
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development...Fullført
-
Mayo ClinicGordon and Betty Moore FoundationFullført
-
University of MichiganThe Craig H. Neilsen FoundationRekrutteringRyggmargsskaderForente stater
-
University of Turin, ItalyFullførtKognitiv svikt | Skrøpelig eldre syndrom | Fysisk avhengighetItalia
-
University of Colorado, DenverUniversity of Southern California; Colorado State University; Clemson UniversityFullførtKronisk sykdomForente stater
-
University College, LondonHar ikke rekruttert ennåBehandlingsoverholdelse og etterlevelse
-
Shenandoah UniversityFullført
-
Aarhus University HospitalRekrutteringVedvarende fysiske symptomerDanmark
-
Washington University School of MedicineAktiv, ikke rekrutterende